Cargando…

Anxiety in heart failure patients and its association with NYHA class

INTRODUCTION: Heart failure (HF) is a worldwide public health problem and the main cause of morbidity and mortality in older people. Previous studies have demonstrated that psychological symptoms are associated with worse cardiovascular outcomes. Nevertheless, the research regarding the association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, F., Martins, S., Moreira, E., Cardoso, J. Silva, Fernandes, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471785/ http://dx.doi.org/10.1192/j.eurpsy.2021.503

Ejemplares similares

The magnitude of depression in heart failure patients and its association with NYHA class
por: Botto, J., et al.
Publicado: (2021)

Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy
por: Briongos‐Figuero, Sem, et al.
Publicado: (2019)

Extracting Features from Poincaré Plots to Distinguish Congestive Heart Failure Patients According to NYHA Classes
por: D’Addio, Giovanni, et al.
Publicado: (2021)

Circulating stem cell vary with NYHA stage in heart failure patients
por: Fortini, Cinzia, et al.
Publicado: (2011)

Skeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients
por: Godard, Michael P, et al.
Publicado: (2012)

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece
por: Athanasakis, Kostas, et al.
Publicado: (2016)

Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective
por: Ademi, Zanfina, et al.
Publicado: (2016)

CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF
por: Zaeem, Faisal, et al.
Publicado: (2012)

Remote monitoring of pulmonary artery pressures with CardioMEMS in patients with chronic heart failure and NYHA class III: first experiences in the Netherlands
por: Brugts, J. J., et al.
Publicado: (2017)

Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study
por: Wechsler, Maximilian, et al.
Publicado: (2022)

Anxiety in heart failure patients and its association with socio-demographic and clinical characteristics: a cross-sectional study
por: Costa, Filipa M. D., et al.
Publicado: (2022)

Using the NYHA Classification as Forecasting Tool for Hospital Readmission and Mortality in Heart Failure Patients with COVID-19
por: Citu, Ioana Mihaela, et al.
Publicado: (2022)

Associations of mood symptoms with NYHA functional classes in angina pectoris patients: a cross-sectional study
por: Yin, Han, et al.
Publicado: (2019)

Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis
por: Cheng, Richard K., et al.
Publicado: (2020)

Study on the Differences between Traditional Chinese Medicine Syndromes in NYHA I–IV Classification of Chronic Heart Failure
por: Shi, Jun, et al.
Publicado: (2019)

Classificação da NYHA e as Variáveis do Teste de Exercício Cardiopulmonar em Pacientes com Insuficiência Cardíaca
por: Costa, Ricardo Vivacqua Cardoso
Publicado: (2022)

Diagnostic accuracy of plasma brain natriuretic peptide for evaluation of dyspnea NYHA-III and NYHA-IV in emergency department of tertiary care hospital
por: Saghir, Hina, et al.
Publicado: (2023)

A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction
por: Mazzoni, Gianni, et al.
Publicado: (2018)

Assessing right ventricular function in pulmonary hypertension patients and the correlation with the New York Heart Association (NYHA) classification
por: Shang, Xiaoke, et al.
Publicado: (2017)

Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm
por: Ferre-Vallverdu, Maria, et al.
Publicado: (2021)

Anxiety symptoms in critically ill COVID-19 survivors and its association with post-discharge health concerns
por: Silva, B., et al.
Publicado: (2022)

Exercise Capacity and Cardiorespiratory Fitness in Children with Congenital Heart Diseases: A Proposal for an Adapted NYHA Classification
por: Neunhaeuserer, Daniel, et al.
Publicado: (2022)

Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study
por: Shuvy, Mony, et al.
Publicado: (2023)

Pulmonary perfusion and NYHA classification improve after cardiac resynchronization therapy
por: Al-Mashat, Mariam, et al.
Publicado: (2021)

Assessing Right Ventricular Function in Patients with Hypertrophic Cardiomyopathy with Cardiac MRI: Correlation with the New York Heart Function Assessment (NYHA) Classification
por: Zhang, Shuai, et al.
Publicado: (2014)

Improvement of exercise tolerance in cardiopulmonary testing with sustained safety after regular training in outpatients with systolic heart failure (NYHA III) and an implantable cardioverter-defibrillator. Prospective 18-month randomized study
por: Smolis-Bąk, Edyta, et al.
Publicado: (2016)

Effects of an 8-month exercise intervention on physical capacity, NT-proBNP, physical activity levels and quality of life data in patients with pulmonary arterial hypertension by NYHA class
por: Santos-Lozano, Alejandro, et al.
Publicado: (2017)

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure
por: Wohlford, George F., et al.
Publicado: (2021)

Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study
por: Valdiviesso, Rui, et al.
Publicado: (2023)

An Anxious Heart: The Relation Between Cardiovascular Disease and Prevalence of Anxiety Symptoms
por: De Sousa, R., et al.
Publicado: (2022)

Transendocardial, autologous bone-marrow cell transplant in severe, chronic ischemic heart failure
por: Dohman, HF, et al.
Publicado: (2003)

The Future of Telemedicine in the Management of Heart Failure Patients
por: Silva-Cardoso, José, et al.
Publicado: (2021)

Admissional B-type natriuretic peptide is an independent predictor of outcome in patients with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2003)

Assessment of heart failure parameters by telemonitoring patients with an implantable cardioverter defibrillator
por: Fily, M, et al.
Publicado: (2022)

51 Enrolling Heart Failure Patients for the Mighty Heart Study: Challenges and Solutions During COVID-19 Pandemic
por: Ellison, M.L., et al.
Publicado: (2021)

Narcolepsy and anxiety. Is this association possible?
por: Martinez, G.M. Ruiz, et al.
Publicado: (2021)

1866. Adverse Outcomes Associated with Potentially Inappropriate Antibiotic Use in Heart Failure Admissions
por: Frisbee, Jason, et al.
Publicado: (2018)

SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis
por: Cardoso, Rhanderson, et al.
Publicado: (2021)

Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
por: Ito, Miyuki, et al.
Publicado: (2022)

Activation of the HeartLogic algorithm on top of heart failure care: a multicenter propensity-matched cohort analysis
por: Feijen, M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qe3gpk8hl4pv5ou68829rm8kkg